|
Peregrine Pharmaceuticals, Inc.
(NASDAQ: PPHM)
Peregrine Pharmaceuticals is a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer.
|
Advancing Pipeline 
Peregrine is advancing first-in-class monoclonal antibodies.
Read more...
|
Upcoming Event
2013 ASCO Annual Meeting
May 31 - June 4, 2013
Read more...
|
Biomanufacturing 
Our subsidiary Avid Bioservices provides a comprehensive range of biomanufacturing services.
Read more...
|
New Data Publication
Measuring Response to Therapy By Near-infrared Imaging of Tumors Using A Phosphatidylserine-targeting Antibody Fragment
View Abstract
|
Patients/Physicians 
Learn about our clinical trials
Read more...
|
Corporate Fact Sheet
March 2013
Download
|
| 2012 Annual Report
Download our 2012 Annual Report to shareholders
Download...
|
Job Seekers
Experienced professionals can choose from current openings posted on our job list.
View current openings...
|
|
